Schwartz Jeffrey Lawrence — SEC insider filings
SEC reporting owner CIK 1702957. 15 insider filings on record with FilingPulse; latest filed 2026-09-10.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2020-10-26 to 2026-09-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 3,433,333 shares, $11,999,999 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 4 legs across 4 filings — 4,203,890 shares, $223,897,942 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: sale of 1,450,000 shares @ $71.50 ($103,675,000) in SpringWorks Therapeutics, Inc., filed 2021-03-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| SpringWorks Therapeutics, Inc. (SWTX) | Director | 6 | — | 3 legs · 4,200,000 sh · $223,800,000 | 6 |
| Aptinyx Inc. (APTX) | 10% owner | 1 | 1 leg · 3,333,333 sh · $9,999,999 | — | — |
| RAPID MICRO BIOSYSTEMS, INC. (RPID) | Director, 10% owner | 5 | 1 leg · 100,000 sh · $2,000,000 | — | 9 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | Director, 10% owner | 2 | — | 1 leg · 3,890 sh · $97,942 | 2 |
| BCLS Acquisition Corp. (BLSA) | Chief Executive Officer, Director, 10% owner | 1 | — | — | 1 |
Insider filings — Schwartz Jeffrey Lawrence
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-10 | 4 | KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | Sale (S): 3,890 @ $25.18 · Grant/award (A): 7,217 | EDGAR |
| 2025-09-08 | 4 | KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | Grant/award (A): 10,909 | EDGAR |
| 2024-05-28 | 4 | RAPID MICRO BIOSYSTEMS, INC. (RPID) | Grant/award (A): 14,300 @ $0 · Grant/award (A): 28,650 (derivative) @ $0 | EDGAR |
| 2023-05-25 | 4 | SpringWorks Therapeutics, Inc. (SWTX) | Grant/award (A): 4,648 @ $0 · Grant/award (A): 13,774 (derivative) @ $0 | EDGAR |
| 2023-05-05 | 4 | RAPID MICRO BIOSYSTEMS, INC. (RPID) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-03-20 | 4 | SpringWorks Therapeutics, Inc. (SWTX) | Sale (S): 1,750,000 @ $28.50 | EDGAR |
| 2022-06-10 | 4 | RAPID MICRO BIOSYSTEMS, INC. (RPID) | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2022-05-20 | 4 | SpringWorks Therapeutics, Inc. (SWTX) | Grant/award (A): 4,818 @ $0 · Grant/award (A): 15,318 (derivative) @ $0 | EDGAR |
| 2021-08-12 | 4 | SpringWorks Therapeutics, Inc. (SWTX) jointly with Bain Capital Life Sciences Investors, LLC, BC SW, LP, Koppel Adam | Sale (S): 1,000,000 @ $70.25 | EDGAR |
| 2021-07-21 | 4 | RAPID MICRO BIOSYSTEMS, INC. (RPID) jointly with Bain Capital Life Sciences Investors, LLC, Bain Capital Life Sciences Partners, LP, Bain Capital Life Sciences Fund, L.P., BCIP Life Sciences Associates, LP, Koppel Adam | Conversion (C): 6,999,998 · Conversion (C): 1,334,562 · Purchase (P): 100,000 @ $20 · Conversion (C): 35,000,001 (derivative) · Conversion (C): 6,672,819 (derivative) | EDGAR |
| 2021-07-16 | 4 | RAPID MICRO BIOSYSTEMS, INC. (RPID) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-05-24 | 4 | SpringWorks Therapeutics, Inc. (SWTX) | Grant/award (A): 1,106 @ $0 · Grant/award (A): 6,998 (derivative) @ $0 | EDGAR |
| 2021-03-11 | 4 | SpringWorks Therapeutics, Inc. (SWTX) jointly with Bain Capital Life Sciences Investors, LLC, BC SW, LP, Koppel Adam | Sale (S): 1,450,000 @ $71.50 | EDGAR |
| 2020-10-27 | 4 | Aptinyx Inc. (APTX) jointly with Bain Capital Life Sciences Investors, LLC, Bain Capital Life Sciences Partners, LP, Bain Capital Life Sciences Fund, L.P., BCIP Life Sciences Associates, LP, Koppel Adam | Purchase (P): 3,333,333 @ $3 | EDGAR |
| 2020-10-26 | 4 | BCLS Acquisition Corp. (BLSA) | Grant/award (A): 487,500 @ $10 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1702957 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs